Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ptc Therapeutics (PTCT)

Ptc Therapeutics (PTCT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,972,463
  • Shares Outstanding, K 61,631
  • Annual Sales, $ 264,730 K
  • Annual Income, $ -128,080 K
  • 60-Month Beta 1.90
  • Price/Sales 11.45
  • Price/Cash Flow N/A
  • Price/Book 4.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.64
  • Number of Estimates 2
  • High Estimate -0.51
  • Low Estimate -0.78
  • Prior Year -0.46
  • Growth Rate Est. (year over year) -39.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.06 +18.49%
on 11/12/19
50.96 -4.53%
on 12/05/19
+7.47 (+18.14%)
since 11/08/19
3-Month
31.49 +54.49%
on 10/02/19
50.96 -4.53%
on 12/05/19
+6.38 (+15.09%)
since 09/10/19
52-Week
27.53 +76.72%
on 01/28/19
50.96 -4.53%
on 12/05/19
+14.13 (+40.93%)
since 12/10/18

Most Recent Stories

More News
Ptc Therapeutics Set to Possibly Pullback After Yesterday's Rally of 1.53%

Ptc Therapeutics (NASDAQ:PTCT) traded in a range yesterday that spanned from a low of $48.01 to a high of $49.73. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high...

PTCT : 48.65 (+0.87%)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on November 25, 2019 it approved non-statutory stock options to purchase an aggregate of 144,550 shares of its common stock to 36 new employees....

PTCT : 48.65 (+0.87%)
Uptrend Call Working As Ptc Therapeutics Stock Rises 23.5% (PTCT)

SmarTrend identified an Uptrend for Ptc Therapeutics (NASDAQ:PTCT) on October 23rd, 2019 at $37.80. In approximately 1 month, Ptc Therapeutics has returned 23.53% as of today's recent price of $46.69....

PTCT : 48.65 (+0.87%)
Roche's NDA for SMA Drug Risdiplam Gets Priority Review

The FDA accepts Roche's (RHHBY) NDA for risdiplam under a priority review to treat spinal muscular atrophy. A verdict is pending on May 24, 2020.

RHHBY : 38.4000 (+0.01%)
NVS : 92.80 (+0.29%)
BIIB : 297.20 (+0.56%)
PTCT : 48.65 (+0.87%)
Ptc Therapeutics Rises 5.09% on Heavy Volume: Watch For Potential Pullback

Ptc Therapeutics (NASDAQ:PTCT) traded in a range yesterday that spanned from a low of $44.28 to a high of $47.40. Yesterday, the shares gained 5.1%, which took the trading range above the 3-day high...

PTCT : 48.65 (+0.87%)
PTC Therapeutics Announces FDA Grants Priority Review to Risdiplam for the Treatment of Spinal Muscular Atrophy

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the United States Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) for risdiplam (RG7916) for...

PTCT : 48.65 (+0.87%)
First Week of January 2020 Options Trading For PTC Therapeutics (PTCT)

Investors in PTC Therapeutics Inc saw new options begin trading this week, for the January 2020 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PTCT options chain...

PTCT : 48.65 (+0.87%)
Ptc Therapeutics Falls 2.28% on Heavy Volume: Watch For Potential Rebound

Ptc Therapeutics (NASDAQ:PTCT) traded in a range yesterday that spanned from a low of $42.42 to a high of $43.78. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of...

PTCT : 48.65 (+0.87%)
PTC Therapeutics to Present at the Evercore ISI 2nd Annual HealthCONx Conference

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will participate in a panel discussion titled, "Gene Therapy with Base Business - Extracting Value," at the 2nd Annual Evercore ISI...

PTCT : 48.65 (+0.87%)
Shares of PTCT Up 15.4% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Ptc Therapeutics (NASDAQ:PTCT) on October 23rd, 2019 at $37.80. In approximately 4 weeks, Ptc Therapeutics has returned 15.41% as of today's recent price of $43.62....

PTCT : 48.65 (+0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade PTCT with:

Business Summary

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

See More

Key Turning Points

2nd Resistance Point 49.84
1st Resistance Point 49.25
Last Price 48.65
1st Support Level 48.01
2nd Support Level 47.36

See More

52-Week High 50.96
Last Price 48.65
Fibonacci 61.8% 42.01
Fibonacci 50% 39.24
Fibonacci 38.2% 36.48
52-Week Low 27.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar